HIV treatment in children: latest news

HIV treatment in children resources

  • Children

    This factsheet provides some practical information that you might find useful if you are the parent or carer of an HIV-positive child.With the right treatment...

    From: Factsheets

    Information level Level 2
  • Treatment in children

    There is very good evidence that anti-HIV drugs can work well in babies and children, and there have been big falls in the amount of...

    From: Factsheets

    Information level Level 2
  • HIV treatment in children

    An outline of the issues surrounding anti-HIV therapy in children, highlighting the differences from adults in the course of HIV disease, the choice of medications,...

    From: HIV treatments directory

    Information level Level 4
  • HIV treatment

    HIV treatment can mean a longer and healthier life for children with HIV. This treatment consists of taking a combination of three different anti-HIV drugs....

    From: Booklets

    Information level Level 2

HIV treatment in children features

HIV treatment in children news from aidsmap

More news

HIV treatment in children news selected from other sources

  • Now or Never: The Urgency of Closing the Treatment Gap for Children Living with HIV/AIDS

    It is time for the international community led by UNAIDS to set an ambitious but feasible target for the number of HIV-positive children to be put on treatment. Countries with the highest paediatric HIV burdens, primarily in sub-Saharan Africa, must take the lead to scale up treatment coverage for their HIV-positive children.

    23 July 2014 | AIDS 2014 conference blog
  • New global clinical trial aims to replicate the mysterious “Mississippi baby” success

    Researchers plan to identify 54 HIV-positive infants and treat them with standard antiretroviral drugs, beginning treatment within 48 hours of birth. The team plans to enroll HIV-positive infants across 17 hospitals and clinics in the U.S. and 11 other countries, including Haiti, India, Malawi, South Africa and Thailand.

    18 June 2014 | Scientific American
  • New Initiative To Address Lack Of Paediatric-Specific HIV Treatments

    As the World Health Assembly, a new partnership has been launched by three major public health actors in the field of HIV treatment. The initiative is meant to find improved treatments for children suffering from HIV/AIDS. Although all actors agree that significant progress has been made on adult treatments, children-specific medicines are still lacking.

    21 May 2014 | Intellectual Property Watch
  • No 'Mississippi Baby' in Canada

    Scientists at several institutions pooled their information and found they had five children who appeared to match the Mississippi baby -- they had been treated within several hours of birth and sensitive testing showed little or no sign of HIV. Details of the Canadian cases were presented at the annual meeting last week of the Canadian Association for HIV Research.

    13 May 2014 | MedPage Today
  • ARVs a Bitter Pill to Swallow for Ugandan Children

    For many of the 35,500 children in Uganda on HIV treatment, daily ARVs are too much of a bitter pill to swallow, especially if they don’t understand why they need them - Uganda’s policy is not to reveal their HIV status to children until they reach 13 years of age.

    08 May 2014 | Inter Press Service
  • HIV disappears in 'Los Angeles baby,' doctors say

    The girl, who was born in April and is being referred to as the "Los Angeles baby," remains on three standard HIV medications. Because of this, doctors cannot say for certain yet whether the infant is cured or whether the disease has gone into remission.

    06 March 2014 | Los Angeles Times
  • Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection: What's New

    Key changes made by the Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children (the Panel) to update the November 1, 2012, Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection are summarized below.

    17 February 2014 | AIDSinfo
  • HIV-infected teens delaying treatment until advanced disease, US study shows

    Nearly half of HIV-infected teenagers and young adults forego timely treatment, delaying care until their disease has advanced, which puts them at risk for dangerous infections and long-term complications, according to a study led by the Johns Hopkins Children's Center.

    04 February 2014 | Eurekalert Inf Dis
  • Merck Receives FDA Approval for ISENTRESS(R) (raltegravir) for Pediatric Oral Suspension

    The oral suspension may be used in patients as young as four weeks of age, weighing at least 3 kg to less than 20 kg. The safety and efficacy of ISENTRESS have not been established in infants less than four weeks of age. Formulations of ISENTRESS for specific populations now include oral suspension, chewable tablets and film-coated tablets.

    09 January 2014 | Wall Street Journal
  • Janssen Announces First-of-its-Kind Drug Donation Program for HIV Treatment-Experienced Children

    Through this program, Janssen will donate its HIV medicines PREZISTA® (darunavir) and INTELENCE® (etravirine), including child-friendly formulations, free of charge to eligible countries with the clinical capacity and willingness to address second- and third-line pediatric HIV treatment. Each child enrolled will receive Janssen’s donated HIV medicines as needed until they turn 19 at which point they will be transitioned into the adult national HIV program or other designated by the national HIV program for continued treatment.

    10 December 2013 | Johnson & Johnson press release
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.

See also